Skip to main content
SpringerLink
Log in

Staging of Bipolar Disorder

  • Chapter
  • First Online:
Bipolar Disorder

Abstract

After the revolution which was brought with the introduction of operationalized diagnostic criteria by contemporary classification systems, the reliability and the validity of psychiatric diagnosis were greatly improved. Following the improvement in categorical diagnosis, two new needs emerge. The first is to explore all aspects of symptomatology and quantify severity. This is a function addressed with the use of psychometric and neuropsychological tools. There is much improvement in this field although much remains to be done (see Chap. 14). The second and still unfulfilled need is to define and rate seriousness, progression, changes in physiology and damage made and the extent and the specific characteristics of the disease. ‘Staging’ is the term which defines this procedure and it can provide the clinician with a valuable tool to assist the treatment design.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alessandra MA, Colom F, Pacchiarotti I, Murru A, Scott J, Valenti M, Mazzarini L, Mar Bonnin CD, Jose SM, Serretti A, Vieta E (2013) Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients: a principal component analysis of lifetime pharmacological and biophysic treatment options. Eur Neuropsychopharmacol 23(4):263–275

    Google Scholar 

  • Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LM, Nardin P, Cunha AB, Cereser KM, Santin A, Gottfried C, Salvador M, Kapczinski F, Goncalves CA (2007a) Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 41(6):523–529. doi:10.1016/j.jpsychires.2006.07.013

    PubMed  Google Scholar 

  • Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, Goncalves CA, Kapczinski F (2007b) DNA damage in bipolar disorder. Psychiatry Res 153(1):27–32. doi:10.1016/j.psychres.2006.03.025

    CAS  PubMed  Google Scholar 

  • Andreazza AC, Kapczinski F, Kauer-Sant’Anna M, Walz JC, Bond DJ, Goncalves CA, Young LT, Yatham LN (2009) 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci 34(4):263–271

    PubMed Central  PubMed  Google Scholar 

  • Arango C, Rapado-Castro M, Reig S, Castro-Fornieles J, Gonzalez-Pinto A, Otero S, Baeza I, Moreno C, Graell M, Janssen J, Parellada M, Moreno D, Bargallo N, Desco M (2012) Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry 69(1):16–26. doi:10.1001/archgenpsychiatry.2011.150

    PubMed  Google Scholar 

  • Aronson TA, Shukla S, Gujavarty K, Hoff A, DiBuono M, Khan E (1988a) Relapse in delusional depression: a retrospective study of the course of treatment. Compr Psychiatry 29(1):12–21

    CAS  PubMed  Google Scholar 

  • Aronson TA, Shukla S, Hoff A, Cook B (1988b) Proposed delusional depression subtypes: preliminary evidence from a retrospective study of phenomenology and treatment course. J Affect Disord 14(1):69–74

    CAS  PubMed  Google Scholar 

  • Bai YM, Su TP, Tsai SJ, Wen-Fei C, Li CT, Pei-Chi T, Mu-Hong C (2014) Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder. J Affect Disord 166:187–192. doi:10.1016/j.jad.2014.05.009

    CAS  PubMed  Google Scholar 

  • Balanza-Martinez V, Tabares-Seisdedos R, Selva-Vera G, Martinez-Aran A, Torrent C, Salazar-Fraile J, Leal-Cercos C, Vieta E, Gomez-Beneyto M (2005) Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study. Psychother Psychosom 74(2):113–119. doi:10.1159/000083170

    PubMed  Google Scholar 

  • Baldessarini RJ, Tondo L, Visioli C (2014) First-episode types in bipolar disorder: predictive associations with later illness. Acta Psychiatr Scand 129(5):383–392. doi:10.1111/acps.12204

    CAS  PubMed  Google Scholar 

  • Berk M (2009) Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int J Neuropsychopharmacol 12(4):441–445. doi:10.1017/S1461145708009498

    CAS  PubMed  Google Scholar 

  • Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S, Yatham LN, Yung A, McGorry P (2007a) Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord 9(7):671–678. doi:10.1111/j.1399-5618.2007.00484.x

    PubMed  Google Scholar 

  • Berk M, Hallam KT, McGorry PD (2007b) The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord 100(1–3):279–281. doi:10.1016/j.jad.2007.03.007

    PubMed  Google Scholar 

  • Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI (2008) N-acetyl cysteine for depressive symptoms in bipolar disorder–a double-blind randomized placebo-controlled trial. Biol Psychiatry 64(6):468–475. doi:10.1016/j.biopsych.2008.04.022

    CAS  PubMed  Google Scholar 

  • Berk M, Hallam K, Malhi GS, Henry L, Hasty M, Macneil C, Yucel M, Pantelis C, Murphy B, Vieta E, Dodd S, McGorry PD (2010) Evidence and implications for early intervention in bipolar disorder. J Ment Health 19(2):113–126. doi:10.3109/09638230903469111

    PubMed  Google Scholar 

  • Berk M, Brnabic A, Dodd S, Kelin K, Tohen M, Malhi GS, Berk L, Conus P, McGorry PD (2011a) Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord 13(1):87–98. doi:10.1111/j.1399-5618.2011.00889.x

    PubMed  Google Scholar 

  • Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yucel M, Gama CS, Dodd S, Dean B, Magalhaes PV, Amminger P, McGorry P, Malhi GS (2011b) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35(3):804–817. doi:10.1016/j.neubiorev.2010.10.001

    CAS  PubMed  Google Scholar 

  • Berk M, Berk L, Udina M, Moylan S, Stafford L, Hallam K, Goldstone S, McGorry PD (2012) Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope, and building morale. Aust N Z J Psychiatry 46(2):92–99. doi:10.1177/0004867411432072

    PubMed  Google Scholar 

  • Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, Conus P, Bechdolf A, Moylan S, Malhi GS (2014) Stage managing bipolar disorder. Bipolar Disord 16(5):471–477. doi:10.1111/bdi.12099

    PubMed  Google Scholar 

  • Blumberg HP, Krystal JH, Bansal R, Martin A, Dziura J, Durkin K, Martin L, Gerard E, Charney DS, Peterson BS (2006) Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol Psychiatry 59(7):611–618. doi:10.1016/j.biopsych.2005.08.031

    CAS  PubMed  Google Scholar 

  • Bora E, Fornito A, Yucel M, Pantelis C (2010) Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry 67(11):1097–1105. doi:10.1016/j.biopsych.2010.01.020

    PubMed  Google Scholar 

  • Brietzke E, Kapczinski F (2008) TNF-alpha as a molecular target in bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 32(6):1355–1361. doi:10.1016/j.pnpbp.2008.01.006

    CAS  Google Scholar 

  • Brietzke E, Stertz L, Fernandes BS, Kauer-Sant’anna M, Mascarenhas M, Escosteguy Vargas A, Chies JA, Kapczinski F (2009) Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 116(3):214–217. doi:10.1016/j.jad.2008.12.001

    CAS  PubMed  Google Scholar 

  • Carlson GA, Goodwin FK (1973) The stages of mania. A longitudinal analysis of the manic episode. Arch Gen Psychiatry 28(2):221–228

    CAS  PubMed  Google Scholar 

  • Carvalho AF, Dimellis D, Gonda X, Vieta E, McLntyre RS, Fountoulakis KN (2014) Rapid cycling in bipolar disorder: a systematic review. J Clin Psychiatry 75(6):e578–e586. doi:10.4088/JCP.13r08905

    PubMed  Google Scholar 

  • Cavanagh JT, Van Beck M, Muir W, Blackwood DH (2002) Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 180:320–326

    CAS  PubMed  Google Scholar 

  • Chang CC, Jou SH, Lin TT, Liu CS (2014) Mitochondrial DNA variation and increased oxidative damage in euthymic patients with bipolar disorder. Psychiatry Clin Neurosci 68(7):551–557. doi:10.1111/pcn.12163

    CAS  PubMed  Google Scholar 

  • Clark L, Iversen SD, Goodwin GM (2002) Sustained attention deficit in bipolar disorder. Br J Psychiatry 180:313–319

    PubMed  Google Scholar 

  • Cosci F, Fava GA (2013) Staging of mental disorders: systematic review. Psychother Psychosom 82(1):20–34. doi:10.1159/000342243

    PubMed  Google Scholar 

  • Cunha AB, Andreazza AC, Gomes FA, Frey BN, da Silveira LE, Goncalves CA, Kapczinski F (2008) Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 258(5):300–304. doi:10.1007/s00406-007-0797-0

    PubMed  Google Scholar 

  • Denicoff KD, Ali SO, Mirsky AF, Smith-Jackson EE, Leverich GS, Duncan CC, Connell EG, Post RM (1999) Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder. J Affect Disord 56(1):67–73, S0165-0327(99)00028-2 [pii]

    CAS  PubMed  Google Scholar 

  • Duffy A, Alda M, Hajek T, Sherry SB, Grof P (2010) Early stages in the development of bipolar disorder. J Affect Disord 121(1–2):127–135. doi:10.1016/j.jad.2009.05.022

    PubMed  Google Scholar 

  • El-Badri SM, Ashton CH, Moore PB, Marsh VR, Ferrier IN (2001) Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder. Bipolar Disord 3(2):79–87

    CAS  PubMed  Google Scholar 

  • Fava GA (1999) Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med 29(1):47–61

    CAS  PubMed  Google Scholar 

  • Fava GA, Kellner R (1993) Staging: a neglected dimension in psychiatric classification. Acta Psychiatr Scand 87(4):225–230

    CAS  PubMed  Google Scholar 

  • Fernandes BS, Gama CS, Cereser KM, Yatham LN, Fries GR, Colpo G, de Lucena D, Kunz M, Gomes FA, Kapczinski F (2011) Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 45(8):995–1004. doi:10.1016/j.jpsychires.2011.03.002

    PubMed  Google Scholar 

  • Fountoulakis KN (2009) An update of evidence-based treatment of bipolar depression: where do we stand? Curr Opin Psychiatry 23(1):19–24. doi:10.1097/YCO.0b013e328333e132

    Google Scholar 

  • Fountoulakis KN (2012) Refractoriness in bipolar disorder: definitions and evidence-based treatment. CNS Neurosci Ther 18(3):227–237. doi:10.1111/j.1755-5949.2011.00259.x

    CAS  PubMed  Google Scholar 

  • Fountoulakis KN, Vieta E (2008) Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. Int J Neuropsychopharmacol 11(7):999–1029. doi:10.1017/S1461145708009231, S1461145708009231 [pii]

    CAS  PubMed  Google Scholar 

  • Fountoulakis KN, Giannakopoulos P, Kovari E, Bouras C (2008a) Assessing the role of cingulate cortex in bipolar disorder: neuropathological, structural and functional imaging data. Brain Res Rev 59(1):9–21. doi:10.1016/j.brainresrev.2008.04.005

    PubMed  Google Scholar 

  • Fountoulakis KN, Grunze H, Panagiotidis P, Kaprinis G (2008b) Treatment of bipolar depression: an update. J Affect Disord 109(1-2):21–34. doi:10.1016/j.jad.2007.10.016, S0165-0327(07)00378-3 [pii]

    PubMed  Google Scholar 

  • Fountoulakis KN, Vieta E, Bouras C, Notaridis G, Giannakopoulos P, Kaprinis G, Akiskal H (2008c) A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? Int J Neuropsychopharmacol 11(2):269–287. doi:10.1017/S1461145707007821

    CAS  PubMed  Google Scholar 

  • Fountoulakis KN, Kelsoe JR, Akiskal H (2011) Receptor targets for antidepressant therapy in bipolar disorder: an overview. J Affect Disord 138(3):222–238. doi:10.1016/j.jad.2011.04.043, S0165-0327(11)00210-2 [pii]

    PubMed  Google Scholar 

  • Frank E, Nimgaonkar VL, Phillips ML, Kupfer DJ (2014) All the world’s a (clinical) stage: rethinking bipolar disorder from a longitudinal perspective. Mol Psychiatry. doi:10.1038/mp.2014.71

    Google Scholar 

  • Fries GR, Pfaffenseller B, Stertz L, Paz AV, Dargel AA, Kunz M, Kapczinski F (2012) Staging and neuroprogression in bipolar disorder. Curr Psychiatry Rep 14(6):667–675. doi:10.1007/s11920-012-0319-2

    PubMed  Google Scholar 

  • Garcia-Lopez A, De Dios-Perrino C, Ezquiaga E (2009) Polarity of the first episode and predominant polarity in a cohort of bipolar outpatients. Eur Neuropsychopharmacol 19:S571

    Google Scholar 

  • Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J (1989) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321(22):1489–1493. doi:10.1056/NEJM198911303212201

    CAS  PubMed  Google Scholar 

  • Goodwin F, Jamison K (2007) Manic-depressive illness, 2nd edn. Oxford University Press, New York

    Google Scholar 

  • Grande I, Magalhaes PV, Chendo I, Stertz L, Panizutti B, Colpo GD, Rosa AR, Gama CS, Kapczinski F, Vieta E (2014) Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand 129(6):437–444. doi:10.1111/acps.12268

    CAS  PubMed  Google Scholar 

  • Hamilton BA, Naismith SL, Scott EM, Purcell S, Hickie IB (2011) Disability is already pronounced in young people with early stages of affective disorders: data from an early intervention service. J Affect Disord 131(1–3):84–91. doi:10.1016/j.jad.2010.10.052

    PubMed  Google Scholar 

  • Helms PM, Smith RE (1983) Recurrent psychotic depression. Evidence of diagnostic stability. J Affect Disord 5(1):51–54

    CAS  PubMed  Google Scholar 

  • Hickie IB, Scott J, Hermens DF, Scott EM, Naismith SL, Guastella AJ, Glozier N, McGorry PD (2013) Clinical classification in mental health at the cross-roads: which direction next? BMC Med 11:125. doi:10.1186/1741-7015-11-125

    PubMed Central  PubMed  Google Scholar 

  • Insel TR (2010) Rethinking schizophrenia. Nature 468(7321):187–193. doi:10.1038/nature09552

    CAS  PubMed  Google Scholar 

  • Javadapour A, Malhi GS, Ivanovski B, Chen X, Wen W, Sachdev P (2007) Increased anterior cingulate cortex volume in bipolar I disorder. Aust N Z J Psychiatry 41(11):910–916. doi:10.1080/00048670701634978

    PubMed  Google Scholar 

  • Judd LL, Akiskal HS (2003) The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 73(1–2):123–131

    PubMed  Google Scholar 

  • Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB (2002) The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59(6):530–537, yoa20425 [pii]

    PubMed  Google Scholar 

  • Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB (2003) A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60(3):261–269, yoa20225 [pii]

    PubMed  Google Scholar 

  • Judd LL, Schettler PJ, Akiskal HS, Coryell W, Leon AC, Maser JD, Solomon DA (2008) Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. Arch Gen Psychiatry 65(4):386–394. doi:10.1001/archpsyc.65.4.386, 65/4/386 [pii]

    PubMed  Google Scholar 

  • Juster RP, McEwen BS, Lupien SJ (2010) Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev 35(1):2–16. doi:10.1016/j.neubiorev.2009.10.002

    PubMed  Google Scholar 

  • Kapczinski F, Frey BN, Andreazza AC, Kauer-Sant’Anna M, Cunha AB, Post RM (2008a) Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Rev Bras Psiquiatr 30(3):243–245

    PubMed  Google Scholar 

  • Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant’anna M, Grassi-Oliveira R, Post RM (2008b) Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 32(4):675–692. doi:10.1016/j.neubiorev.2007.10.005

    PubMed  Google Scholar 

  • Kapczinski F, Dias VV, Kauer-Sant’Anna M, Brietzke E, Vazquez GH, Vieta E, Berk M (2009a) The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 33(8):1366–1371. doi:10.1016/j.pnpbp.2009.07.027

    CAS  Google Scholar 

  • Kapczinski F, Dias VV, Kauer-Sant’Anna M, Frey BN, Grassi-Oliveira R, Colom F, Berk M (2009b) Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 9(7):957–966. doi:10.1586/ern.09.31

    PubMed  Google Scholar 

  • Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant’Anna M, Klamt F, Pasquali MA, Quevedo J, Gama CS, Post R (2010) A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry 15(8):784–786. doi:10.1038/mp.2009.112

    CAS  PubMed  Google Scholar 

  • Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant’Anna M, Klamt F, Moreira JC, de Bittencourt Pasquali MA, Fries GR, Quevedo J, Gama CS, Post R (2011) Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 45(2):156–161. doi:10.1016/j.jpsychires.2010.05.015

    PubMed  Google Scholar 

  • Kapczinski F, Magalhaes PV, Balanza-Martinez V, Dias VV, Frangou S, Gama CS, Gonzalez-Pinto A, Grande I, Ha K, Kauer-Sant’Anna M, Kunz M, Kupka R, Leboyer M, Lopez-Jaramillo C, Post RM, Rybakowski JK, Scott J, Strejilevitch S, Tohen M, Vazquez G, Yatham L, Vieta E, Berk M (2014) Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force report. Acta Psychiatrica Scand. doi:10.1111/acps.12305

    Google Scholar 

  • Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN (2009) Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol 12(4):447–458. doi:10.1017/S1461145708009310

    PubMed  Google Scholar 

  • Kendler KS, Thornton LM, Gardner CO (2000) Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am J Psychiatry 157(8):1243–1251

    CAS  PubMed  Google Scholar 

  • Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, Tohen M (2006) Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. J Clin Psychiatry 67(1):95–101

    CAS  PubMed  Google Scholar 

  • Lagopoulos J, Hermens DF, Naismith SL, Scott EM, Hickie IB (2012) Frontal lobe changes occur early in the course of affective disorders in young people. BMC Psychiatry 12:4. doi:10.1186/1471-244X-12-4

    PubMed Central  PubMed  Google Scholar 

  • Lebowitz BK, Shear PK, Steed MA, Strakowski SM (2001) Verbal fluency in mania: relationship to number of manic episodes. Neuropsychiatr Neuropsychol Behav Neurol 14(3):177–182

    CAS  Google Scholar 

  • Lewandowski KE, Cohen BM, Ongur D (2011) Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol Med 41(2):225–241. doi:10.1017/S0033291710001042, S0033291710001042 [pii]

    CAS  PubMed  Google Scholar 

  • Lim CS, Baldessarini RJ, Vieta E, Yucel M, Bora E, Sim K (2013) Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev 37(3):418–435. doi:10.1016/j.neubiorev.2013.01.003

    PubMed  Google Scholar 

  • Lin A, Reniers RL, Wood SJ (2013) Clinical staging in severe mental disorder: evidence from neurocognition and neuroimaging. Br J Psychiatry Suppl 54:s11–s17. doi:10.1192/bjp.bp.112.119156

    PubMed  Google Scholar 

  • Lopez-Jaramillo C, Lopera-Vasquez J, Gallo A, Ospina-Duque J, Bell V, Torrent C, Martinez-Aran A, Vieta E (2010) Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord 12(5):557–567. doi:10.1111/j.1399-5618.2010.00835.x

    PubMed  Google Scholar 

  • Magalhaes PV, Jansen K, Pinheiro RT, Klamt F, Teixeira AL, da Silva RA, Kapczinski F (2011) Systemic toxicity in early-stage mood disorders. J Psychiatr Res 45(10):1407–1409. doi:10.1016/j.jpsychires.2011.05.008

    PubMed  Google Scholar 

  • Magalhaes PV, Dodd S, Nierenberg AA, Berk M (2012a) Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Aust N Z J Psychiatry 46(11):1058–1067. doi:10.1177/0004867412460593

    PubMed  Google Scholar 

  • Magalhaes PV, Jansen K, Pinheiro RT, Colpo GD, da Motta LL, Klamt F, da Silva RA, Kapczinski F (2012b) Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. Int J Neuropsychopharmacol 15(8):1043–1050. doi:10.1017/S1461145711001532

    CAS  PubMed  Google Scholar 

  • McGorry PD (2007) Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry 164(6):859–860. doi:10.1176/appi.ajp.164.6.859

    PubMed  Google Scholar 

  • McGorry PD (2010a) Risk syndromes, clinical staging and DSM V: new diagnostic infrastructure for early intervention in psychiatry. Schizophr Res 120(1–3):49–53. doi:10.1016/j.schres.2010.03.016

    PubMed  Google Scholar 

  • McGorry PD (2010b) Staging in neuropsychiatry: a heuristic model for understanding, prevention and treatment. Neurotox Res 18(3–4):244–255. doi:10.1007/s12640-010-9179-x

    PubMed  Google Scholar 

  • McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ (2006) Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 40(8):616–622. doi:10.1111/j.1440-1614.2006.01860.x

    PubMed  Google Scholar 

  • McGorry PD, Purcell R, Hickie IB, Yung AR, Pantelis C, Jackson HJ (2007) Clinical staging: a heuristic model for psychiatry and youth mental health. Med J Aust 187(7 Suppl):S40–S42

    PubMed  Google Scholar 

  • McGorry PD, Killackey E, Yung A (2008) Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 7(3):148–156

    PubMed Central  PubMed  Google Scholar 

  • McGorry PD, Nelson B, Goldstone S, Yung AR (2010) Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Can J Psychiatry 55(8):486–497

    PubMed  Google Scholar 

  • McIntyre RS, Correll C (2014) Predicting and preventing bipolar disorder: the need to fundamentally advance the strategic approach. Bipolar Disord 16(5):451–454. doi:10.1111/bdi.12216

    PubMed  Google Scholar 

  • McNamara RK, Nandagopal JJ, Strakowski SM, DelBello MP (2010) Preventative strategies for early-onset bipolar disorder: towards a clinical staging model. CNS Drugs 24(12):983–996. doi:10.2165/11539700-000000000-00000

    PubMed  Google Scholar 

  • Moore PB, Shepherd DJ, Eccleston D, Macmillan IC, Goswami U, McAllister VL, Ferrier IN (2001) Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br J Psychiatry 178:172–176

    CAS  PubMed  Google Scholar 

  • Moorhead TW, McKirdy J, Sussmann JE, Hall J, Lawrie SM, Johnstone EC, McIntosh AM (2007) Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 62(8):894–900. doi:10.1016/j.biopsych.2007.03.005

    PubMed  Google Scholar 

  • Munkholm K, Poulsen HE, Kessing LV, Vinberg M (2014) Elevated levels of urinary markers of oxidatively generated DNA and RNA damage in bipolar disorder. Bipolar Disord. doi:10.1111/bdi.12245

    PubMed  Google Scholar 

  • Nelson WH, Khan A, Orr WW Jr (1984) Delusional depression. Phenomenology, neuroendocrine function, and tricyclic antidepressant response. J Affect Disord 6(3–4):297–306

    CAS  PubMed  Google Scholar 

  • Nery FG, Chen HH, Hatch JP, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Keshavan MS, Soares JC (2009) Orbitofrontal cortex gray matter volumes in bipolar disorder patients: a region-of-interest MRI study. Bipolar Disord 11(2):145–153. doi:10.1111/j.1399-5618.2009.00662.x

    PubMed  Google Scholar 

  • Perry A, Tarrier N, Morriss R, McCarthy E, Limb K (1999) Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ 318(7177):149–153

    CAS  PubMed Central  PubMed  Google Scholar 

  • Popovic D, Vieta E (2013) Clinical implications of polarity index of drugs in maintenance treatment of bipolar disorder: a naturalistic study. Eur Neuropsychopharmacol 23:S68–S69

    Google Scholar 

  • Post RM (1992) Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149(8):999–1010

    CAS  PubMed  Google Scholar 

  • Post RM (2010) Mechanisms of illness progression in the recurrent affective disorders. Neurotox Res 18(3–4):256–271. doi:10.1007/s12640-010-9182-2

    PubMed  Google Scholar 

  • Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Rush AJ, Keck PE Jr, McElroy SL, Luckenbaugh DA, Pollio C, Kupka R, Nolen WA (2003) Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 64(6):680–690; quiz 738–789

    PubMed  Google Scholar 

  • Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, Leverich GS, Luckenbaugh DA, Rowe M, Pizzarello S, Kupka RW, Grunze H, Nolen WA (2010) Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry 71(9):1176–1186. doi:10.4088/JCP.08m04811yel; quiz 1252–1273

    PubMed  Google Scholar 

  • Post RM, Fleming J, Kapczinski F (2012) Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatr Res 46(5):561–573. doi:10.1016/j.jpsychires.2012.02.004

    PubMed  Google Scholar 

  • Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP (2003) Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121(2):109–122

    CAS  PubMed  Google Scholar 

  • Reinares M, Colom F, Rosa AR, Bonnin CM, Franco C, Sole B, Kapczinski F, Vieta E (2010) The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord 123(1–3):81–86. doi:10.1016/j.jad.2009.09.009

    PubMed  Google Scholar 

  • Reinares M, Papachristou E, Harvey P, Mar Bonnin C, Sanchez-Moreno J, Torrent C, Ayuso-Mateos JL, Ploubidis GB, Vieta E, Frangou S (2013) Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J Affect Disord 144(1–2):65–71. doi:10.1016/j.jad.2012.06.005

    PubMed  Google Scholar 

  • Robinson LJ, Ferrier IN (2006) Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord 8(2):103–116. doi:10.1111/j.1399-5618.2006.00277.x, BDI277 [pii]

    PubMed  Google Scholar 

  • Rosa AR, Frey BN, Andreazza AC, Cereser KM, Cunha AB, Quevedo J, Santin A, Gottfried C, Goncalves CA, Vieta E, Kapczinski F (2006) Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett 407(2):146–150. doi:10.1016/j.neulet.2006.08.026

    CAS  PubMed  Google Scholar 

  • Rosa AR, Gonzalez-Ortega I, Gonzalez-Pinto A, Echeburua E, Comes M, Martinez-Aran A, Ugarte A, Fernandez M, Vieta E (2012) One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder. Acta Psychiatr Scand 125(4):335–341. doi:10.1111/j.1600-0447.2011.01830.x

    CAS  PubMed  Google Scholar 

  • Rosa AR, Magalhaes PV, Czepielewski L, Sulzbach MV, Goi PD, Vieta E, Gama CS, Kapczinski F (2014) Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry 75(5):e450–e456. doi:10.4088/JCP.13m08625

    PubMed  Google Scholar 

  • Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, Abbott R, Hayhurst H (2006) Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry 188:313–320. doi:10.1192/bjp.188.4.313

    PubMed  Google Scholar 

  • Scott J, Leboyer M, Hickie I, Berk M, Kapczinski F, Frank E, Kupfer D, McGorry P (2013) Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry 202(4):243–245. doi:10.1192/bjp.bp.112.110858

    PubMed  Google Scholar 

  • Segal ZV, Williams JM, Teasdale JD, Gemar M (1996) A cognitive science perspective on kindling and episode sensitization in recurrent affective disorder. Psychol Med 26(2):371–380

    CAS  PubMed  Google Scholar 

  • Silverstone T, McPherson H, Li Q, Doyle T (2003) Deep white matter hyperintensities in patients with bipolar depression, unipolar depression and age-matched control subjects. Bipolar Disord 5(1):53–57

    PubMed  Google Scholar 

  • Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH, Nierenberg AA, Fava M, Wong KK (2006) Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 60(5):432–435. doi:10.1016/j.biopsych.2006.02.004

    CAS  PubMed  Google Scholar 

  • Soares JC, Kochunov P, Monkul ES, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Lancaster J, Fox P (2005) Structural brain changes in bipolar disorder using deformation field morphometry. Neuroreport 16(6):541–544

    PubMed  Google Scholar 

  • Strakowski SM, Wilson DR, Tohen M, Woods BT, Douglass AW, Stoll AL (1993) Structural brain abnormalities in first-episode mania. Biol Psychiatry 33(8–9):602–609

    CAS  PubMed  Google Scholar 

  • Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, Shear P, Adler CM (2002) Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry 159(11):1841–1847

    PubMed  Google Scholar 

  • Strejilevich SA, Martino DJ (2013) Cognitive function in adulthood and elderly euthymic bipolar patients: a comparison to test models of cognitive evolution. J Affect Disord 150(3):1188–1191. doi:10.1016/j.jad.2013.05.012

    PubMed  Google Scholar 

  • Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD (1999) Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry 156(8):1264–1266

    CAS  PubMed  Google Scholar 

  • Tohen M, Vieta E, Gonzalez-Pinto A, Reed C, Lin D, European Mania in Bipolar Longitudinal Evaluation of Medication Advisory B (2010) Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania. J Clin Psychiatry 71(3):255–261. doi:10.4088/JCP.08m04580

    PubMed  Google Scholar 

  • Torrent C, Bonnin Cdel M, Martinez-Aran A, Valle J, Amann BL, Gonzalez-Pinto A, Crespo JM, Ibanez A, Garcia-Portilla MP, Tabares-Seisdedos R, Arango C, Colom F, Sole B, Pacchiarotti I, Rosa AR, Ayuso-Mateos JL, Anaya C, Fernandez P, Landin-Romero R, Alonso-Lana S, Ortiz-Gil J, Segura B, Barbeito S, Vega P, Fernandez M, Ugarte A, Subira M, Cerrillo E, Custal N, Menchon JM, Saiz-Ruiz J, Rodao JM, Isella S, Alegria A, Al-Halabi S, Bobes J, Galvan G, Saiz PA, Balanza-Martinez V, Selva G, Fuentes-Dura I, Correa P, Mayoral M, Chiclana G, Merchan-Naranjo J, Rapado-Castro M, Salamero M, Vieta E (2013) Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry 170(8):852–859. doi:10.1176/appi.ajp.2012.12070971

    PubMed  Google Scholar 

  • Torres IJ, DeFreitas VG, DeFreitas CM, Kauer-Sant’Anna M, Bond DJ, Honer WG, Lam RW, Yatham LN (2010) Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry 71(9):1234–1242. doi:10.4088/JCP.08m04997yel

    PubMed  Google Scholar 

  • Vieta E, Reinares M, Rosa AR (2011) Staging bipolar disorder. Neurotox Res 19(2):279–285. doi:10.1007/s12640-010-9197-8

    PubMed  Google Scholar 

  • Vieta E, Popovic D, Rosa AR, Sole B, Grande I, Frey BN, Martinez-Aran A, Sanchez-Moreno J, Balanza-Martinez V, Tabares-Seisdedos R, Kapczinski F (2013) The clinical implications of cognitive impairment and allostatic load in bipolar disorder. E Psychiatry 28(1):21–29. doi:10.1016/j.eurpsy.2011.11.007

    CAS  Google Scholar 

  • Vita A, De Peri L, Sacchetti E (2009) Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies. Bipolar Disord 11(8):807–814. doi:10.1111/j.1399-5618.2009.00759.x

    PubMed  Google Scholar 

  • Walz JC, Andreazza AC, Frey BN, Cacilhas AA, Cereser KM, Cunha AB, Weyne F, Stertz L, Santin A, Goncalves CA, Kapczinski F (2007) Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neurosci Lett 415(1):87–89. doi:10.1016/j.neulet.2007.01.002

    CAS  PubMed  Google Scholar 

  • Walz JC, Magalhaes PV, Giglio LM, Cunha AB, Stertz L, Fries GR, Andreazza AC, Kapczinski F (2009) Increased serum neurotrophin-4/5 levels in bipolar disorder. J Psychiatr Res 43(7):721–723. doi:10.1016/j.jpsychires.2008.10.005

    PubMed  Google Scholar 

  • Yatham LN, Kapczinski F, Andreazza AC, Trevor Young L, Lam RW, Kauer-Sant’anna M (2009) Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. Int J Neuropsychopharmacol 12(1):137–139. doi:10.1017/S1461145708009449

    CAS  PubMed  Google Scholar 

  • Yung AR, McGorry PD (1996) The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 22(2):353–370

    CAS  PubMed  Google Scholar 

  • Yung AR, McGorry PD (2007) Prediction of psychosis: setting the stage. Br J Psychiatry Suppl 51:s1–s8. doi:10.1192/bjp.191.51.s1

    PubMed  Google Scholar 

  • Zubieta JK, Huguelet P, O’Neil RL, Giordani BJ (2001) Cognitive function in euthymic bipolar I disorder. Psychiatry Res 102(1):9–20, S0165-1781(01)00242-6 [pii]

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neurosciences 3rd Department of Psychiatry, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

    Kostas N. Fountoulakis

Authors
  1. Kostas N. Fountoulakis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fountoulakis, K.N. (2015). Staging of Bipolar Disorder. In: Bipolar Disorder. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37216-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-37216-2_15

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-37215-5

  • Online ISBN: 978-3-642-37216-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation